CTSO Cytosorbents Corporation
$4.47▲ +0.00%
Healthcare
Other
Volume 7.1K
Avg Volume (10D) 124.4K
Key Metrics & Fundamentals
Market Cap
$14.09M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.84 - 17.20
% vs 50 MA
-18.39%
% vs 200 MA
-53.81%
RSI-14
47.0
MACD Histogram
+0.2500
Beta (1Y vs SPY)
1.02
Free Cash Flow
-$635,000
Gross Rev
$9.63M
Gross Profit
$7.05M
EBITDA
-$1.99M
COGS
$2.58M
Operating Exp
$9.42M
Operating Income
-$2.37M
EBIT
-$2.37M
Pretax Income
-$4.42M
Net Income
-$4.42M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care
PR Newswire · Sep 30, 2026 7:00 AM ET
CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR Newswire · Sep 23, 2026 7:00 AM ET
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 10, 2026 7:00 AM ET
CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
TMX Newsfile · Sep 4, 2026 9:09 AM ET
CytoSorbents Announces Reverse Stock Split
PR Newswire · Sep 3, 2026 7:00 AM ET
CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor
Zacks Small Cap Research · Sep 3, 2026 5:31 AM ET
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
PR Newswire · Sep 2, 2026 7:28 AM ET
CTSO: CytoSorbents Future Value Drivers Support Price Target of $4.00
Zacks Small Cap Research · Aug 17, 2026 6:06 AM ET
Cytosorbents (CTSO) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 7:29 PM ET
Cytosorbents Corporation Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CTSO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.